Highlights
NASDAQ: IMMU       Immunomedics Inc
Last Price Today's Change   Day's Range   Trading Volume
19.005   -0.345 (1.78%)  18.885 - 19.68  1,238,300

Overview

 
Avg Volume (4 weeks):2,201,688
4 Weeks Range:17.66 - 22.221
4 Weeks Price Volatility (%):
29.49%
52 Weeks Range:11.55 - 22.221
52 Weeks Price Volatility (%):
69.86%
Average Price Target: 8.00
Price Target Upside/Downside: -11.005

Headlines



No recent Headlines for this stock.


Business Background

Immunomedics Inc is a clinical-stage biopharmaceutical company, based in the United States. The company develops monoclonal antibody-based products for the targeted treatment of cancer and autoimmune disorders, among others. Its portfolio of products under investigation include antibody-drug conjugates that target the tumor-reducing toxic effects of chemotherapeutic treatments. The company’s pipeline includes products targeting solid tumors and hematologic malignancies, among other diseases in clinical and preclinical development. The company is marketing specific diagnostic imaging agents to detect bone infections in Europe, Canada, and Australia. The company has subsidiaries in the Netherlands and Germany to manage sales and clinical trials in Europe.

  Be the first to like this.
 


 

3414  4674  636  186 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.67+0.30 
 TTNP 0.334+0.084 
 SPY 331.95+1.03 
 SNCA 1.60+0.35 
 EEM 46.23+0.26 
 AVP 5.60-0.05 
 AMD 50.93+1.16 
 CHK 0.661-0.029 
 BAC 34.71-0.01 
 GE 11.81-0.03 
Partners & Brokers